Genfit S.A. ( GNFT) - Key Metrics
Stock symbol GNFT is outdated, potentially delisted? Maybe it is available on other exchange?
GNFT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $1.23 | $0.61 | -$0.23 | -$0.24 |
| 2023Q4 | $0.29 | ? | -$0.61 | -$0.62 |
| 2023Q2 | $0.23 | -$0.42 | -$0.52 | -$0.56 |
| 2022Q4 | ? | ? | ? | ? |
| 2022Q2 | $0.18 | -$0.21 | -$0.98 | -$0.98 |
GNFT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | 1.53 |
| 2023Q4 | ? | ? |
| 2023Q2 | ? | -2.09 |
| 2022Q4 | ? | ? |
| 2022Q2 | ? | -3.65 |
GNFT
Price: $8.95
52 week price:
Earnings Per Share: -0.90 USD
P/E Ratio: -10.02
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 944
Market Capitalization: 449.2 million